Robert F. Kennedy Jr. & United States — White House

Robert F. Kennedy Jr.: Robert F. Kennedy Jr.'s efforts to rewrite U.S. vaccine policy as Health Secretary have led to lawsuits and political scrutiny, influencing the shake-up at the United States — Food and Drug Administration.

United States — White House: The United States — White House has exerted more control over the United States — United States Department of Health and Human Services and the United States — Food and Drug Administration, installing Chris Klomp to bring in more conventional nominees and address vaccine policy concerns.

Robert F. Kennedy Jr.: Robert F. Kennedy Jr., as Health Secretary, stated that his team would share details of the drug pricing deals that do not include proprietary information or trade secrets, in response to calls for transparency.

United States — White House: The United States — White House, through its Council of Economic Advisers, released an analysis estimating substantial savings from Donald Trump's drug pricing deals, supporting the administration's policy claims.

Robert F. Kennedy Jr.: As the U.S. Health Secretary, Robert F. Kennedy Jr. is the driving force behind the initiatives to reduce SSRI use and explored potential bans, despite his department's denial of ban discussions. His past claims linking SSRIs to violence and fetal risks lack evidence.

United States — White House: Robert F. Kennedy Jr. agreed to pivot his policy focus after months of tension with the United States — White House, indicating political influence on his agenda.